• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒肺炎患者脂质谱改变及脂质在预测住院时间方面的价值

Alteration of lipid profile and value of lipids in the prediction of the length of hospital stay in COVID-19 pneumonia patients.

作者信息

Qin Chen, Minghan Huang, Ziwen Zhao, Yukun Luo

机构信息

Department of Cardiology Fujian Medical University Union Hospital Fuzhou China.

Fujian Institute of Coronary Artery Disease Fuzhou China.

出版信息

Food Sci Nutr. 2020 Oct 27;8(11):6144-6152. doi: 10.1002/fsn3.1907. eCollection 2020 Nov.

DOI:10.1002/fsn3.1907
PMID:33282265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7684619/
Abstract

To observe lipid profiles and their alterations in hospitalized patients with COVID-19 pneumonia (NCP) and evaluate the value of lipids for the prediction of the length of hospital stay (LOS), a total of 248 patients aged 18 years or older were enrolled in this retrospective study. At admission, the median levels of triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) in all patients were 1.11, 4.00, 0.89, and 2.11 mmol/L, respectively. Compared with common cases ( = 174), severe cases ( = 74) exhibited higher TG and HDL-C, and lower LDL-C. Levels of TC and LDL-C were negatively correlated with LOS. In 68 severe cases, serum lipids were followed up during hospitalization, and the median LOS was 29 days. The average levels of serum lipids were lowest at admission and gradually increased during hospitalization. Compared with the LOS ≤ 29 days group, serum levels of TC, HDL-C, and LDL-C were significantly lower in the LOS > 29 days group at admission; this lower trend was found in the subsequent tests for TC and LDL-C but not for HDL-C or TG. Multiple-variant COX regression showed that levels of TC or LDL-C at admission were independent risk of LOS prolongation. Together, these findings suggest that in patients with NCP, levels of TC and LDL-C at admission were negatively correlated with LOS. In severe cases, the gradual increase in TC, LDL-C, and HDL-C during hospitalization might indicate gradual recovery. TC < 3.75 mmol/L or LDL-C < 1.7 mmol/L at admission may act as an independent predictor of prolonged LOS.

摘要

为观察新型冠状病毒肺炎(NCP)住院患者的血脂谱及其变化,并评估血脂对预测住院时间(LOS)的价值,本回顾性研究共纳入248例18岁及以上患者。入院时,所有患者的甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)和低密度脂蛋白胆固醇(LDL-C)的中位数水平分别为1.11、4.00、0.89和2.11 mmol/L。与普通病例(n = 174)相比,重症病例(n = 74)的TG和HDL-C较高,而LDL-C较低。TC和LDL-C水平与LOS呈负相关。在68例重症病例中,住院期间对血脂进行了随访,中位LOS为29天。血脂的平均水平在入院时最低,并在住院期间逐渐升高。与LOS≤29天组相比,LOS>29天组入院时血清TC、HDL-C和LDL-C水平显著较低;在随后的TC和LDL-C检测中发现了这种下降趋势,但HDL-C或TG未发现。多变量COX回归显示,入院时TC或LDL-C水平是LOS延长的独立危险因素。总之,这些发现表明,在NCP患者中,入院时TC和LDL-C水平与LOS呈负相关。在重症病例中,住院期间TC、LDL-C和HDL-C的逐渐升高可能表明病情在逐渐恢复。入院时TC<3.75 mmol/L或LDL-C<1.7 mmol/L可能是LOS延长的独立预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d55/7684619/70b2089af169/FSN3-8-6144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d55/7684619/6ebeed3d4074/FSN3-8-6144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d55/7684619/a6b61a223cef/FSN3-8-6144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d55/7684619/70b2089af169/FSN3-8-6144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d55/7684619/6ebeed3d4074/FSN3-8-6144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d55/7684619/a6b61a223cef/FSN3-8-6144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d55/7684619/70b2089af169/FSN3-8-6144-g003.jpg

相似文献

1
Alteration of lipid profile and value of lipids in the prediction of the length of hospital stay in COVID-19 pneumonia patients.新冠病毒肺炎患者脂质谱改变及脂质在预测住院时间方面的价值
Food Sci Nutr. 2020 Oct 27;8(11):6144-6152. doi: 10.1002/fsn3.1907. eCollection 2020 Nov.
2
[The gender features of disorders of composition of lipids of blood serum in patients with chronic pathology of kidneys.].[慢性肾脏病理患者血清脂质成分紊乱的性别特征。]
Klin Lab Diagn. 2018;63(3):152-158. doi: 10.18821/0869-2084-2018-63-3-152-158.
3
Recommended reference values for serum lipids during early and middle pregnancy: a retrospective study from China.推荐早孕期和中孕期血清脂质的参考值范围:来自中国的回顾性研究。
Lipids Health Dis. 2018 Oct 31;17(1):246. doi: 10.1186/s12944-018-0885-3.
4
Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.刚果动脉高血压患者血清脂质和脂蛋白的相关因素
Cardiovasc J S Afr. 2005 Sep-Oct;16(5):249-55.
5
[Prognostic value of PCSK9 and blood lipid in patients with sepsis].[前蛋白转化酶枯草溶菌素9(PCSK9)和血脂在脓毒症患者中的预后价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Jun;34(6):614-619. doi: 10.3760/cma.j.cn121430-20211220-01887.
6
Correlation Analysis and Intervention Study on Disturbance of Lipid Metabolism and Diabetic Peripheral Neuropathy.血脂代谢紊乱与糖尿病周围神经病变的相关性分析及干预研究。
Comput Math Methods Med. 2022 Feb 22;2022:2579692. doi: 10.1155/2022/2579692. eCollection 2022.
7
The analysis of the lipid levels in patients with coronary artery disease after percutaneous coronary intervention: a one-year follow-up observational study.经皮冠状动脉介入治疗后冠心病患者血脂水平分析:一项为期一年的随访观察研究。
Lipids Health Dis. 2020 Jul 6;19(1):163. doi: 10.1186/s12944-020-01340-5.
8
[Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].[新疆阜康市30岁以上哈萨克族人群血脂水平及相关因素的流行病学调查]
Zhonghua Yu Fang Yi Xue Za Zhi. 2011 May;45(5):440-3.
9
[Comparison and application of postprandial and fasting blood lipid levels in 839 physical examinees in Beijing].[北京839名体检者餐后与空腹血脂水平的比较及应用]
Zhonghua Yu Fang Yi Xue Za Zhi. 2021 Feb 6;55(2):245-252. doi: 10.3760/cma.j.cn112150-20200512-00719.
10
Role of Lipid Profile and Its Relative Ratios (Cholesterol/HDL-C, Triglyceride/HDL-C, LDL-C/HDL-C, WBC/HDL-C, and FBG/HDL-C) on Admission Predicts In-Hospital Mortality COVID-19.入院时血脂谱及其相对比值(胆固醇/高密度脂蛋白胆固醇、甘油三酯/高密度脂蛋白胆固醇、低密度脂蛋白胆固醇/高密度脂蛋白胆固醇、白细胞/高密度脂蛋白胆固醇和空腹血糖/高密度脂蛋白胆固醇)对预测 COVID-19 患者院内死亡率的作用
J Lipids. 2023 Mar 6;2023:6329873. doi: 10.1155/2023/6329873. eCollection 2023.

引用本文的文献

1
Analysis of risk-factors associated with hospital-acquired pneumonia in patients with alzheimer's disease based on gender differences.基于性别差异分析阿尔茨海默病患者医院获得性肺炎的相关危险因素。
BMC Geriatr. 2025 Aug 4;25(1):587. doi: 10.1186/s12877-025-06276-y.
2
Association Between Lipid Profile and COVID-19 Severity: Insights from a Single-Center Cross-Sectional Study in Northern Greece.血脂谱与新冠病毒疾病严重程度之间的关联:来自希腊北部一项单中心横断面研究的见解
J Clin Med. 2025 Jun 9;14(12):4082. doi: 10.3390/jcm14124082.
3
The clinical value of triglyceride to high-density lipoprotein cholesterol ratio for predicting stroke-associated pneumonia after spontaneous intracerebral hemorrhage.

本文引用的文献

1
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal.COVID-19 诊断和预后预测模型:系统评价和批判性评估。
BMJ. 2020 Apr 7;369:m1328. doi: 10.1136/bmj.m1328.
2
Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk.家族性高胆固醇血症与2019冠状病毒病:引发持续升高的心血管风险
J Intern Med. 2020 Jun;287(6):746-747. doi: 10.1111/joim.13070. Epub 2020 Apr 22.
3
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis.
甘油三酯与高密度脂蛋白胆固醇比值对预测自发性脑出血后卒中相关性肺炎的临床价值。
BMC Neurol. 2025 Apr 9;25(1):148. doi: 10.1186/s12883-025-04154-z.
4
High-density lipoproteins and COVID-19: preparing the next pandemic.高密度脂蛋白与2019冠状病毒病:为下一场大流行做准备
J Lipid Res. 2025 May;66(5):100779. doi: 10.1016/j.jlr.2025.100779. Epub 2025 Mar 14.
5
Influence of time factor and albuminuria on characteristics of patients with type 2 diabetes Mellitus before, during and 1 year after COVID-19 recovery.时间因素和蛋白尿对2型糖尿病患者在新冠病毒病康复前、康复期间及康复后1年特征的影响
Diabetol Metab Syndr. 2023 Jun 13;15(1):126. doi: 10.1186/s13098-023-01104-y.
6
Overview of the cardio-metabolic impact of the COVID-19 pandemic.新冠疫情对心血管代谢影响概述。
Endocrine. 2023 Jun;80(3):477-490. doi: 10.1007/s12020-023-03337-3. Epub 2023 Apr 27.
7
Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19.低密度脂蛋白颗粒表型变化可作为 COVID-19 不良临床结局的标志物。
Mol Genet Metab. 2023 Apr;138(4):107552. doi: 10.1016/j.ymgme.2023.107552. Epub 2023 Feb 27.
8
A Review of Routine Laboratory Biomarkers for the Detection of Severe COVID-19 Disease.用于检测重症 COVID-19 疾病的常规实验室生物标志物综述
Int J Anal Chem. 2022 Oct 11;2022:9006487. doi: 10.1155/2022/9006487. eCollection 2022.
9
Prognostic significance of HDL-C on long-term mortality in patients with COVID-19 pneumonia in the Turkish population: A potential mechanism for population differences.在土耳其人群中,COVID-19 肺炎患者的 HDL-C 对长期死亡率的预后意义:人群差异的潜在机制。
Bosn J Basic Med Sci. 2022 Oct 23;22(6):1016-1024. doi: 10.17305/bjbms.2022.7545.
10
SARS-CoV2 Infection and Comorbidities, Role in Oncogenesis.SARS-CoV2 感染与合并症,在肿瘤发生中的作用。
Asian Pac J Cancer Prev. 2022 Jul 1;23(7):2191-2197. doi: 10.31557/APJCP.2022.23.7.2191.
新型冠状病毒 SARS-CoV-2 感染患者的影像学和临床特征:系统评价和荟萃分析。
J Med Virol. 2020 Sep;92(9):1449-1459. doi: 10.1002/jmv.25822. Epub 2020 Apr 10.
4
Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis.中国武汉 95 例 2019 年新型冠状病毒肺炎的临床特征和实验室结果分析:回顾性分析。
Respir Res. 2020 Mar 26;21(1):74. doi: 10.1186/s12931-020-01338-8.
5
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.基于对来自中国武汉的150名患者数据的分析得出的COVID-19相关死亡的临床预测因素。
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
6
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
7
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
9
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南:通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
10
Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus.阿托伐他汀限制了流感病毒生成脂滴的能力,并严重抑制了病毒的复制。
FASEB J. 2019 Aug;33(8):9516-9525. doi: 10.1096/fj.201900428RR. Epub 2019 May 24.